Citing a cost-containment campaign, drug distributor Bergen...

Citing a cost-containment campaign, drug distributor Bergen Brunswig Corp. reported increases in both earnings and revenue for its first fiscal quarter. Earnings for the three months ended Dec. 31 increased 31% to $13.5 million, or 36 cents a share, from $10.3 million, or 28 cents a share, a year earlier. Revenue rose to a record $2 billion, from $1.8 billion in 1993.

The company, which provides pharmaceuticals and health and beauty aids through distribution facilities nationwide, is “extremely pleased with our progress and the continued favorable results,” said Robert E. Martini, chairman and chief executive of the Orange-based firm.